Australia
Australia as a Strategic Gateway: The Economic and Regulatory Advantages of Clinical Manufacturing Down Under
Mark W. Womack; Jan Bekker; Melissa El Khouri
BioCina
PAO-07-25-CL-01Jul 14, 2025
mRNA Manufacturing
Navigating mRNA Manufacturing with Flexibility and Innovation
Michael van der Horst, Ph.D.
Wacker
PAO-04-24-CL-02Apr 08, 2024
mRNA–LNP Manufacturing
The Innovators Bringing Continuous Manufacturing to Lipid Nanoparticles
Antonio Costa, Ph.D.; William Pasek
DIANT Pharma
PAO-03-24-CL-08Mar 18, 2024
CDMO
Maximizing Outsourcing Benefits for Virtual Pharma Companies
William Kazimier
Tedor Pharma Services
PAO-09-23-CL-08Jan 11, 2024
Lipid Nanoparticles
Facilitating Development and Scale-Up of Nanoparticle Drug Products with an End-to-End Adaptable Manufacturing Platform
Antonio Costa, Ph.D.
DIANT Pharma
PAO-10-23-CL-03Nov 01, 2023
CDMO Partnerships
Webinar: A Developer's Guide to Partnering With the Right CDMO, Presented by Samsung Biologics
Samsung Biologics
PAO-08-23-PATV-01Aug 16, 2023
Clinical and Commercial Manufacturing
Reach the Patient Quicker with GBI’s Manufacturing Solutions
Muctarr Sesay, Ph.D.
GBI
PAO-08-23-CL-02Aug 08, 2023
New Integrated mRNA Offering
Building on Experience and Investing in an Integrated mRNA Offering
Jessica Madigan; Normand Blais
BIOVECTRA
PAO-07-23-CL-03Jul 31, 2023
Expanded CDMO Capabilities
On the Journey to Support Drug Developers With End-to-End Outsourcing
Michelle Hall
Mikart
PAO-06-23-CL-04Jul 17, 2023
CDMO Partnerships
Why Choosing the Right CDMO Partner is Essential in Today’s Pharmaceutical Market
Daniel Buckley
Samsung Biologics
PAO-05-23-CL-07Jun 19, 2023
Lipid Nanoparticles
Facilitating Lipid Nanoparticle Production with a Unique Continuous Manufacturing Solution
Antonio Costa, Ph.D.; William Pasek
DIANT Pharma
PAO-04-23-CL-05May 06, 2023
Microbiome Therapeutic Innovation
Unleashing the Power of the Microbiome: Advancements, Challenges, and the Therapeutic Future
Stacy Burns-Guydish, Ph.D.; Gary Henderson
List Labs
PAO-03-23-CL-08Apr 04, 2023
Viral Vector Manufacturing
Considerations in Viral Vector Analytical Development to Enable Smooth Transfer to Quality Control
Chris Berger; Kilian Witzel
Avid Bioservices
PAO-02-23-CL-03Mar 14, 2023
mRNA Ultra-Cold Chain Management
Ultra-Cold Chain and Supply Chain Management Strategies for mRNA
Eunseo (Ency) Lee, Ph.D; Jungkeun (Henry) Oh; Hanel Hwang
Samsung Biologics
PAO-02-23-CL-09Mar 09, 2023
Pharmaceutical Consultancy
Staying Ahead of the Curve with Outsourced Program Management
PharmaLex
PAO-02-23-PATV-01Feb 07, 2023
Controlled Substances in Clinical Trials
Controlled Substances in Clinical Trials: Considerations, Challenges, and Growing Demand
Rich Nelson; John Hufnagel; Rachel Castro
PCI Pharma Services
PAO-01-23-CL-03Jan 30, 2023
Overcoming the Challenges of an Ever-changing Biopharma Landscape
Integrity
PAO-01-23-PATV-01Jan 24, 2023
Quality by Design
A Concerted QbD Approach to Development and Manufacturing of Nucleic Acid Therapies
Lynda Menard, Ph.D.; Grant Henderson, Ph.D.
Vernal Biosciences
PAO-11-022-CL-06Jan 10, 2023
Microbiome-Based CDMO
Expanding a Leadership Position in Microbiome-Based Contract Development and Manufacturing
Stacy Burns-Guydish, Ph.D.; Jonathan Yongwan Jo; Gary Henderson; Michael Kimble
List Labs
PAO-11-022-CL-13Dec 13, 2022
Biomanufacturing
New Name, Same Expertise: Goodwin Biotechnology is Becoming GBI!
Danielle Alvarez
Pharma's Almanac
PAO-11-022-CL-11Dec 05, 2022